MASIMO CORP 4

Accession 0000937556-17-000065

$MASICIK 0000937556operating

View on SEC.gov Company Profile

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:18 PM ET

Size

25.6 KB

Accession

0000937556-17-000065

Insider Transaction Report

Form 4

Period: 2017-03-31

MASIMO CORPMASI

de Raad Mark

EVP & Chief Financial Officer

Transactions

Exercise/Conversion
Common Stock
2017-03-31$37.84/sh+6,000$227,040→ 14,660 total
Sale
Common Stock
2017-03-31$93.13/sh−6,000$558,794→ 8,660 total
Sale
Common Stock
2017-03-31$93.14/sh−12,000$1,117,620→ 8,660 total
Exercise/Conversion
Common Stock
2017-03-31$31.01/sh+12,000$372,120→ 20,660 total
Exercise/Conversion
Common Stock
2017-04-03$21.97/sh+12,000$263,640→ 20,660 total
Sale
Common Stock
2017-04-03$93.31/sh−12,000$1,119,745→ 8,660 total
Exercise/Conversion
Common Stock
2017-04-04$28.03/sh+18,000$504,540→ 26,660 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-04-03$21.97/sh−12,000$263,640→ 12,000 total
Exercise: $21.97From: 2014-05-28Exp: 2023-05-28→ Common Stock (12,000 underlying)
Sale
Common Stock
2017-04-04$93.34/sh−18,000$1,680,037→ 8,660 total
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-31$31.01/sh−12,000$372,120→ 18,000 total
Exercise: $31.01From: 2016-03-20Exp: 2025-03-20→ Common Stock (12,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-03-31$37.84/sh−6,000$227,040→ 24,000 total
Exercise: $37.84From: 2017-02-28Exp: 2026-02-28→ Common Stock (6,000 underlying)
Exercise/Conversion
Non-Qualified Stock Option (Right to Buy)
2017-04-04$28.03/sh−18,000$504,540→ 12,000 total
Exercise: $28.03From: 2015-02-18Exp: 2024-02-18→ Common Stock (18,000 underlying)

Footnotes (9)

[F1]The shares covered by this Form 4 were exercised and sold pursuant to a Rule 10b5-1 Sales Plan dated as of March 17, 2017, which is intended to comply with Rule 10b5-1 promulgated under the Securities Exchange Act of 1934, as amended.
[F2]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.77 per share to a high of $93.48 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F3]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $93.50 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F4]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.76 per share to a high of $94.67 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F5]The price reported in Column 4 represents the weighted average sale price per share. The actual sale prices ranged from a low of $92.94 per share to a high of $93.83 per share. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F6]This option was granted on February 29, 2016 and is exercisable as the option vests. The option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
[F7]This option was granted on March 20, 2015 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
[F8]This option was granted on May 28, 2013 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.
[F9]This option was granted on February 18, 2014 and is exercisable as the option vests. This option vests over a five year period, with 20% of the shares subject to the option vesting on each anniversary of the grant date.

Documents

1 file

4
wf-form4_149134066727654.xmlPrimary
FORM 4

Issuer

MASIMO CORP

CIK 0000937556

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000937556

Filing Metadata

Form type: 4
Filed: Apr 3, 8:00 PM ET
Accepted: Apr 4, 5:18 PM ET
Size: 25.6 KB

View on SEC.gov